CHRISTINE MORRIS: Open Payments
NPI 1003501875 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$930 in 47 payments from 11 companies in 2025. Trend: 2023 $70 · 2024 $832 · 2025 $930
Food & beverage: $930
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $182 |
| ABBVIE INC. | 14 | $160 |
| Neurocrine BioSciences, Inc. | 6 | $129 |
| Lundbeck LLC | 5 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $101 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| HARMONY BIOSCIENCES LLC | 1 | $22 |
Products named: REXULTI, ARISTADA, VRAYLAR, INGREZZA, CAPLYTA, Auvelity, Qelbree, COBENFY.
Industry payments across AL — which companies pay providers there.
